DARAPRIM (Amedra Pharmaceuticals LLC)
Welcome to the PulseAid listing for the DARAPRIM drug offered from Amedra Pharmaceuticals LLC. This Dihydrofolate Reductase Inhibitor Antimalarial [EPC],Dihydrofolate Reductase Inhibitors [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: | Amedra Pharmaceuticals LLC |
NON-PROPRIETARY NAME: | pyrimethamine |
SUBSTANCE NAME: | PYRIMETHAMINE |
TYPE: | HUMAN PRESCRIPTION DRUG |
PHARMA CLASS: | Dihydrofolate Reductase Inhibitor Antimalarial [EPC],Dihydrofolate Reductase Inhibitors [MoA] |
ROUTE: | ORAL |
DOSAGE FORM: | TABLET |
MARKETING CATEGORY NAME: | NDA |
START MARKETING DATE: | 1953-01-23 |
END MARKETING DATE: | 0000-00-00 |
DARAPRIM HUMAN PRESCRIPTION DRUG Details:
Item Description | DARAPRIM from Amedra Pharmaceuticals LLC |
LABELER NAME: | Amedra Pharmaceuticals LLC |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 25(mg/1) |
START MARKETING DATE: | 1953-01-23 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 52054-330_3eb574dd-5a57-4b26-a2ba-46202d3931d3 |
PRODUCT NDC: | 52054-330 |
APPLICATION NUMBER: | NDA008578 |
Other PYRIMETHAMINE Pharmaceutical Manufacturers / Labelers: